198 related articles for article (PubMed ID: 12868560)
1. In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates.
Kantarcioglu AS; Yucel A; Vidotto V
J Chemother; 2003 Jun; 15(3):296-8. PubMed ID: 12868560
[No Abstract] [Full Text] [Related]
2. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
3. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).
Messer SA; Moet GJ; Kirby JT; Jones RN
J Clin Microbiol; 2009 Jun; 47(6):1942-6. PubMed ID: 19386851
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
[TBL] [Abstract][Full Text] [Related]
5. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
6. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis.
Kakeya H; Miyazaki Y; Senda H; Kobayashi T; Seki M; Izumikawa K; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2008 May; 52(5):1871-2. PubMed ID: 18299408
[TBL] [Abstract][Full Text] [Related]
8. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.
Du W; Gao Y; Liu L; Sai S; Ding C
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576268
[TBL] [Abstract][Full Text] [Related]
9. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
Pfaller MA; Messer SA; Jones RN; Castanheira M
J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
Strippoli V; Torosantucci A; Simonetti N
Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Mitsuyama J; Nomura N; Hashimoto K; Yamada E; Nishikawa H; Kaeriyama M; Kimura A; Todo Y; Narita H
Antimicrob Agents Chemother; 2008 Apr; 52(4):1318-24. PubMed ID: 18227186
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
Kamai Y; Harasaki T; Fukuoka T; Ohya S; Uchida K; Yamaguchi H; Kuwahara S
Antimicrob Agents Chemother; 2002 Feb; 46(2):367-70. PubMed ID: 11796343
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of C-27 steroidal saponins.
Yang CR; Zhang Y; Jacob MR; Khan SI; Zhang YJ; Li XC
Antimicrob Agents Chemother; 2006 May; 50(5):1710-4. PubMed ID: 16641439
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antifungal evaluation of 7-arylamino-5,8-dioxo-5,8-dihydroisoquinoline-4-carboxylates.
Ryu CK; Song AL; Hong JA
Bioorg Med Chem Lett; 2013 Apr; 23(7):2065-8. PubMed ID: 23453842
[TBL] [Abstract][Full Text] [Related]
18. Characterization and antibiotic sensitivity patterns of yeast-like organisms.
Deshpande SD; Shetty CR; Murti PK
J Postgrad Med; 1986 Jan; 32(1):14-7. PubMed ID: 3528467
[No Abstract] [Full Text] [Related]
19. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
20. Combination antifungals: an update.
Segal BH; Steinbach WJ
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]